Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
about
Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances.Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma.Schedule-dependent synergistic effect of rituximab on methotrexate chemotherapy against lymphoma of the central nervous systemSystems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.Epstein-Barr virus-associated primary central nervous system cytotoxic T-cell lymphoma.[F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [F]FDG in human xenograft models
P2860
Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and MRI of rituximab ...... ude rat model of CNS lymphoma.
@en
Efficacy and MRI of rituximab ...... ude rat model of CNS lymphoma.
@nl
type
label
Efficacy and MRI of rituximab ...... ude rat model of CNS lymphoma.
@en
Efficacy and MRI of rituximab ...... ude rat model of CNS lymphoma.
@nl
prefLabel
Efficacy and MRI of rituximab ...... ude rat model of CNS lymphoma.
@en
Efficacy and MRI of rituximab ...... ude rat model of CNS lymphoma.
@nl
P2093
P2860
P1433
P1476
Efficacy and MRI of rituximab ...... ude rat model of CNS lymphoma.
@en
P2093
Carole Soussain
Csanad G Varallyay
Dale F Kraemer
Kristoph Jahnke
Leslie L Muldoon
Robert D Brown
Seth J Lewin
P2860
P304
P356
10.1215/15228517-2008-119
P577
2009-01-21T00:00:00Z